Sanofi

SNYleader

Sanofi is a French multinational pharmaceutical company anchored by blockbuster biologic Dupixent (co-developed with Regeneron) and one of the world's largest vaccine businesses.

⇄ Compare

Produk & Pendapatan

Pangsa Pendapatan Produk

Komposisi Pendapatan ($46.1B)

Data statis (memuat keuangan langsung…)

Biopharma (55%)

Vaccines (18%)

General Medicines (18%)

Consumer Healthcare (9%)

Komposisi segmen dan pelanggan utama

Detail produk

Dupixent30%

Blockbuster biologic for atopic dermatitis, asthma, and other inflammatory conditions

Vaccines (Sanofi Pasteur)20%

Flu vaccines, pediatric combinations, and Beyfortus (RSV)

General Medicines30%

Lantus insulin, Plavix, and mature drug portfolio

Specialty Care & Consumer20%

Rare disease treatments and consumer healthcare

Hubungan Rantai Pasok

Mitra

Regeneron Pharmaceuticals

Dupixent co-development and profit sharing

Dampak: Critical — Regeneron develops key drug

Pesaing

Pfizer Inc.

Vaccines and respiratory

Dampak: Medium — vaccine market competition

AstraZeneca

Respiratory and immunology

Dampak: Medium — overlapping therapeutic areas

Konteks makro dan pasar

제약 / 바이오Berita sektor

GLP-1 메가트렌드 + AI 신약개발 + 저평가 바이오 기관 매집

GLP-1 시장 규모 (2030E)

$150B

mRNA 암백신 임상 성공률

+49% 재발 위험 감소

AI 신약개발 단계

임상 2상 진입

PFE/MRNA 52주 변화

-30% ~ -45%

Katalis mendatang

◆LLY Orforglipron(경구용 GLP-1) 3상 결과 (2026.Q2)◆MRNA 암백신 FDA BLA 제출 예정◆REGN EYLEA HD 유럽 허가 결과

Berita terkini

Memuat berita...

Analisis AI

Klik "Dapatkan Analisis AI" untuk analisis rantai pasok Sanofi.

Info Perusahaan

Kantor Pusat

Paris, France

Didirikan

2004

Karyawan

91,000+

Situs Web

sanofi.com

Gambaran umum sektor — 제약 / 바이오

Berita sektor